Cardiotoxicity in Pediatric Cancer Survivorship: Retrospective Cohort Study

Area of Science:

• Pediatric Oncology
• Cardiovascular Medicine
• Epidemiology

Background:

• Improved pediatric cancer survival rates highlight long-term treatment effects.
• Cardiovascular complications are a major cause of morbidity and mortality in survivors.
• Understanding cardiotoxicity is vital for risk stratification and care planning.

Purpose of the Study:

• To investigate the prevalence, incidence, and risk factors of cardiotoxicity in pediatric cancer survivors.
• To identify specific cardiovascular complications and their associated predictors.
• To develop a risk prediction model for cardiotoxicity.

Main Methods:

• Retrospective cohort study of 24,938 five-year childhood cancer survivors (1970-1999).
• Assessment of cardiovascular complications via questionnaires and medical records.
• Cox proportional hazards models and multivariable logistic regression for risk factor analysis and model development.

Main Results:

• Cumulative incidence of cardiovascular complications by 30 years postdiagnosis was 18.7%.
• Significant risk factors: anthracycline exposure (HR 2.31), chest radiation (HR 1.84), older age, male sex, obesity.
• Risk prediction model showed good discrimination (C-statistic 0.78). Survivors had 3.7 times higher risk than siblings.

Conclusions:

• Pediatric cancer survivors face a significant, persistent risk of cardiovascular complications.
• Identified risk factors and prediction model aid personalized follow-up and interventions.
• Lifelong cardiovascular monitoring is essential for this population.